Table 1

Epidemiological and clinical characteristics of COVID-19 children with or without GI symptoms

GI symptoms (n=34)Non-GI symptoms (n=210)P value
Age (months)
 Median (IQR)14 (3–93)86 (28–139)0.01*
Age group distribution (n (%))0.02*
 0–1 month2 (5.9)9 (4.3)
 1 month-12 months14 (41.2)30 (14.3)
 1–3 years old4 (11.8)23 (11.0)
 3–6 years old3 (8.8)24 (11.4)
 6–10 years old5 (14.7)61 (29.1)
 10–18 years old6 (17.6)63 (30.0)
Sex (male) (n (%))19 (55.9)131 (62.4)0.47
Birth weight (kg)3.3 (2.9–3.7)3.3 (3.0–3.6)0.90
Clinical diagnostic classification (n (%))0.47
 Asymptomatic0 (0)51 (24.3)<0.01*
 Acute upper respiratory infection7 (20.6)43 (20.4)
 Mild pneumonia25 (73.5)107 (51.0)
 Severe pneumonia0 (0)7 (3.3)
 Critical pneumonia2 (5.9)2 (1.0)
Contact history with infected family member28 (79.4)180 (85.7)0.62
Symptoms (n (%))
 Fever24 (70.6)75 (35.7)<0.01*
 Vomit23 (67.7)
 Diarrhoea15 (44.1)
 Abdominal pain4 (11.8)
 Decreased feeding8 (23.5)
Stool SARS-CoV-2 RT-PCR results (105 patients tested) (n (%))
 Positive7/17 (41.2)32/88 (36.4)0.70
  • *denotes statistical significance.

  • SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.